Study of bone marrow stem cells in multiple sclerosis
PhysOrg.com - Evergreen,VA,USA
A new pilot clinical trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis has started at Frenchay Hospital. ...
See all stories on this topic

Opexa Therapeutics Names Dawn McGuire, Multiple Sclerosis Clinical ...
Trading Markets - Los Angeles,CA,USA
... as we advance our lead product Tovaxin, an autologous vaccine currently in Phase IIb clinical trials for multiple sclerosis, through development."
See all stories on this topic

Multiple Sclerosis Patients Find Dietary Treatment More Effective Than Pharmaceutical Regimens
Medical News Today Wed, 26 Sep 2007 1:14 AM PDT
MS sufferers, who have found little benefit from drug treatments, are finding success in a diet that targets five food triggers. Sugar and saturated fats also contribute to the disease process. By identifying and eliminating food sensitivities, along with other simple dietary changes, the MS Recovery Diet can halt and reverse symptoms for those afflicted with MS. [click link for full article]

Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of ...
The San Francisco Examiner Wed, 26 Sep 2007 10:40 AM PDT
CAMBRIDGE, Mass. ( Map ) - Genzyme Corporation (Nasdaq: GENZ ) and Bayer Schering Pharma AG, Germany today announced that the first patient has been treated in the first of two planned Phase 3 trials examining the safety and efficacy of alemtuzumab for the treatment of multiple sclerosis (MS).

Gulf veterans need care, panel is told
Miami Herald Wed, 26 Sep 2007 0:12 AM PDT
Sixteen years after the Persian Gulf War ended, more than one in four of those who fought remain seriously ill with medical problems, including severe fatigue and joint pain, Lou Gehrig's disease, multiple sclerosis and brain cancer, the chairman of a congressional advisory committee testified Tuesday.

Campath MS testing moves forward
Boston Globe - United States
Genzyme Corp. of Cambridge and its German partner Bayer Schering Pharma AG appear to be moving closer to seeking approval to use their cancer drug, Campath, ...
See all stories on this topic

BTG says Campath licensees begin phase III
Hemscott - London,UK
LONDON (Thomson Financial) - BTG PLC said its licensee, Genzyme Corp and Bayer Schering Pharma AG have started phase III trial of Campath (alemtuzumab), ...
See all stories on this topic

Opexa Therapeutics Names Dawn McGuire, Multiple Sclerosis Clinical ...
RTT News - Williamsville,NY,USA
Commenting on the appointment, Opexa's chief executive officer, David McWilliams said, "Her understanding of clinical trial design and the regulatory ...
See all stories on this topic